This new publication proposes an analyzis of pharma companies’ reputation and practical recommendations to improve the opinion of their core stakeholders.
News
This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance...
In this position paper – the first of our 2023 Medical Series – we provide insights and...
In this position paper we have selected and analyzed 5 key topics that are specific to the...